Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma
Authors:
- Wen-Kai WengWWWen-Kai Weng
- Chaitanya IragavarapuCIChaitanya Iragavarapu
- Gavin M. WengGWGavin M. Weng
- Richard T. HoppeRHRichard T. Hoppe
- Susan HinikerSHSusan Hiniker
- Michael S. KhodadoustMKMichael S. Khodadoust
- Youn H. KimYKYoun H. Kim
Open Access
- 29 March 2024
- journal article
- research article
- Published by Elsevier in Blood Neoplasia
- Vol. 1 (2)
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative DisordersJAMA Dermatology, 2022
- Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral LegsPractical Radiation Oncology, 2019
- Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian populationInternational Journal of Hematology, 2018
- Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomasLaboratory Investigation, 2017
- Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results DatabaseClinical Lymphoma Myeloma and Leukemia, 2016
- Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphomaJournal of the American Academy of Dermatology, 2015
- Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First AllograftsTransplantation and Cellular Therapy, 2009
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningLeukemia, 2006
- Protective Conditioning for Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 2005